Graf Akcie ABT (Abbott Laboratories). Diskuze k akciím ABT. Aktuální informace ABT.

Základní informace o společnosti Abbott Laboratories (Akcie ABT)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 207.73B
Hodnota podniku (EV) 231.39B
Tržby 40.233B
EBITDA 9.459B
Zisk 6.376B
Růst v tržbách Q/Q 39.51 %
Růst v tržbách Y/Y 27.95 %
P/E (Cena vůči ziskům) 32.91
Forward P/E 0.01
EV/Sales 5.75
EV/EBITDA 24.46
EV/EBIT 29.87
PEG 2.96
Price/Sales 5.16
P/FCF 24.03
Price/Book 6.29
Účetní hodnota na akcii 18.67
Hotovost na akcii 4.04
FCF vůči ceně 4.16 %
Počet zaměstnanců 109,000
Tržba na zaměstnance 369.110k
Profit margin 12.99 %
Operating margin 18.46 %
Gross margin 56.65 %
EBIT margin 19.25 %
EBITDA margin 23.51 %
EPS - Zisk na akcii 3.57
EPS - Kvartální růst 105.26 %
EPS - Očekávaný růst příští rok -5.10 %
Return on assets 8.87 %
Return on equity 19.26 %
ROIC 7.89 %
ROCE 12.77 %
Dluhy/Equity 1.20
Čistý dluh/EBITDA 4.76
Current ratio 1.79
Quick Ratio 1.36
Volatilita 1.62
Beta 0.52
RSI 38.14
Cílová cena analytiků 120
Známka akcie (dle analytiků) 1.76
Insider ownership 0.72 %
Institutional ownership 75.71 %
Počet akcií 1.773B
Procento shortovaných akcií 0.81 %
Short ratio 1.77 %
Dividenda 1.80
Procentuální dividenda 1.53 %
Dividenda/Zisk 50.42 %
Obchodovaná od 1978
Země United States

Finanční výsledky akcie ABT

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$34,608$31,904$30,578$27,390$20,853$20,405
Cost Of Goods Sold$15,003$13,231$12,706$12,409$9,094$8,747
Gross Profit$19,605$18,673$17,872$14,981$11,759$11,658
Research And Development Expenses$2,420$2,440$2,300$2,260$1,447$1,405
SG&A Expenses$9,696$9,765$9,744$9,182$6,736$6,785
Other Operating Income Or Expenses------
Operating Expenses$29,251$27,372$26,928$25,826$17,827$17,538
Operating Income$5,357$4,532$3,650$1,564$3,026$2,867
Total Non-Operating Income/Expense$-389$-455$-777$667$-1,613$316
Pre-Tax Income$4,968$4,077$2,873$2,231$1,413$3,183
Income Taxes$497$390$539$1,878$350$577
Income After Taxes$4,471$3,687$2,334$353$1,063$2,606
Other Income------
Income From Continuous Operations$4,471$3,687$2,334$353$1,063$2,606
Income From Discontinued Operations$24-$34$124$337$1,817
Net Income$4,495$3,687$2,368$477$1,400$4,423
EBITDA$8,684$7,546$6,960$5,497$4,544$4,339
EBIT$5,357$4,532$3,650$1,564$3,026$2,867
Basic Shares Outstanding1,7731,7681,7581,7401,4771,496
Shares Outstanding1,7861,7811,7701,7491,4831,506
Basic EPS$2.52$2.07$1.34$0.27$0.94$2.94
EPS - Earnings Per Share$2.50$2.06$1.33$0.27$0.94$2.92
# 2020 2019 2018 2017 2016 2015
Current Ratio1.71671.44221.62362.26074.02041.5409
Long-term Debt / Capital0.35950.34740.38660.46670.49960.2159
Debt/Equity Ratio0.5680.57950.63690.89791.06220.4221
Gross Margin56.648858.528758.447354.695156.3957.1331
Operating Margin15.479114.205111.93675.710114.511114.0505
EBIT Margin15.479114.205111.93675.710114.511114.0505
EBITDA Margin25.092523.652222.761520.069421.790621.2644
Pre-Tax Profit Margin14.355112.7799.39568.14536.77615.5991
Net Profit Margin12.988311.55667.74411.74156.713721.6761
Asset Turnover0.4770.470.45520.35920.39590.4947
Inventory Turnover Ratio2.99343.06563.34723.4463.73623.3655
Receiveable Turnover5.39575.88095.90085.21816.42035.9699
Days Sales In Receivables67.646562.065161.855969.948356.851361.1404
ROE - Return On Equity13.547311.77927.59721.13515.131112.2198
Return On Tangible Equity-80.9231-41.3387-20.3416-2.452212.513242.54
ROA - Return On Assets6.16285.43113.47460.4632.01846.318
ROI - Return On Investment8.67657.68734.66050.60542.56789.5819
Book Value Per Share18.632817.759417.499217.835514.065814.4812
Operating Cash Flow Per Share0.9786-0.1140.37461.02490.1903-0.4372
Free Cash Flow Per Share0.6794-0.24630.23611.13180.1715-0.469